Home › Funds › D. E. Shaw & Co › ALGS
D. E. Shaw & Co position in ALGS
ALIGOS THERAPEUTICS INC · Health Care
Latest position (Q2 2026)66.46K sh
Reported value held$383.49K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 20.77K | $45.00K | New |
| Q2 2022 | 154.87K | $187.00K | Add |
| Q3 2022 | 31.57K | $35.00K | Reduce |
| Q1 2026 | 10.98K | $81.57K | New |
| Q2 2026 | 66.46K | $383.49K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALGS
- Vanguard Group 200.40K sh · $1.87M · Q4 2025
- Marshall Wace 246.58K sh · $1.42M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 76.25K sh · $439.94K · Q2 2026
- UBS Group AG 59.99K sh · $346.12K · Q2 2026
- Geode Capital Management 47.17K sh · $272.32K · Q2 2026
- BlackRock Inc 30.29K sh · $174.78K · Q2 2026
- Renaissance Technologies 10.80K sh · $62.32K · Q2 2026
- Citigroup Inc 1.81K sh · $10.43K · Q2 2026
- JPMorgan Chase & Co 344 sh · $1.87K · Q2 2026
- Morgan Stanley 204 sh · $1.18K · Q2 2026
- Wells Fargo & Co 100 sh · $577 · Q2 2026